CNC
GILD icon

Citizens & Northern Corp’s Gilead Sciences GILD Stock Holding History

Citizens & Northern Corp’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-9,910
Closed -$701K – 99
2017
Q2 		$701K Sell
9,910
-6,199
-38% -$413K 0.55% 62
2017
Q1 		$1.09M Buy
16,109
+383
+2% +$26.9K 0.88% 47
2016
Q4 		$1.13M Buy
15,726
+464
+3% +$34.5K 0.85% 45
2016
Q3 		$1.21M Buy
15,262
+978
+7% +$79.4K 0.95% 43
2016
Q2 		$1.19M Buy
14,284
+4,354
+44% +$386K 0.93% 44
2016
Q1 		$912K Buy
9,930
+1,613
+19% +$145K 0.72% 50
2015
Q4 		$842K Buy
8,317
+59
+0.7% +$6.14K 0.69% 50
2015
Q3 		$811K Buy
8,258
+378
+5% +$42K 0.63% 57
2015
Q2 		$923K Buy
7,880
+45
+0.6% +$4.92K 0.71% 48
2015
Q1 		$769K Buy
7,835
+794
+11% +$80.6K 0.58% 77
2014
Q4 		$664K Buy
+7,041
New +$728K 0.5% 88

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citizens & Northern Corp's GILD Position: Q3 2017 in Review

Citizens & Northern Corp sold out of Gilead Sciences (GILD) in Q3 2017, closing a stake of 9,910 shares — an estimated $701K sold.

Citizens & Northern Corp first reported a position in GILD in Q4 2014 and held it in 11 quarters. The position peaked at $1.21M in Q3 2016. 1,503 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

  • Citizens & Northern Corp reported no remaining Gilead Sciences position as of Q3 2017 after selling out during the quarter.
  • Citizens & Northern Corp sold 9,910 Gilead Sciences shares in Q3 2017, an estimated $701K.
  • Citizens & Northern Corp first reported a position in Gilead Sciences in Q4 2014 and held it in 11 quarters.
  • Citizens & Northern Corp's Gilead Sciences position peaked at $1.21M in Q3 2016.
  • 1,503 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on Citizens & Northern Corp's 13F filing for Q3 2017, filed 13 Nov 2017.